Neurotech plays an important role when it comes to detecting early signs of a stroke or Alzheimer’s disease. Or treating depression and anxiety attacks.
This talk on the future of neuroscience, health and neurotech features Mary Lou Jepsen, founder & CEO of Openwater and Howard Lee Morgan, Chair of B Capital Group and co-founder of First Round Capital.
Dr. Mary Lou Jepsen is CEO and Founder of Openwater, a breakthrough medical technology company in diagnostics and therapeutics. Previously, Dr. Jepsen served at Facebook & Oculus and Director of Engineering at Google.
Howard Lee Morgan is one of the pioneers of early-stage investing. He serves as Chair of B Capital Group, a multi-stage global fund based in Singapore and Manhattan Beach. He also helped found Idealab, one of the earliest technology incubators.
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information